Vanda Pharmaceuticals (VNDA) EBITDA Margin Growth (5y) (2015 - 2026)
Vanda Pharmaceuticals (VNDA) EBITDA Margin Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Vanda Pharmaceuticals | 318.71 Mn | 116.40 Mn | 48.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11,361.00 |
| Dec 31, 2025 | -8,598.00 |
| Sep 30, 2025 | -6,845.00 |
| Jun 30, 2025 | -8,796.00 |
| Mar 31, 2025 | -8,177.00 |
| Dec 31, 2024 | -2,629.00 |
| Sep 30, 2024 | -4,117.00 |
| Jun 30, 2024 | -3,686.00 |
| Mar 31, 2024 | -1,508.00 |
| Dec 31, 2023 | -3,292.00 |
| Sep 30, 2023 | -2,813.00 |
| Jun 30, 2023 | -1,449.00 |
| Mar 31, 2023 | -240.00 |
| Dec 31, 2022 | 1,514.00 |
| Sep 30, 2022 | 1,789.00 |
| Jun 30, 2022 | 995.00 |
| Mar 31, 2022 | 839.00 |
| Dec 31, 2021 | 1,441.00 |
| Sep 30, 2021 | 1,713.00 |
| Jun 30, 2021 | 3,151.00 |